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Abstract
Protein crystallization in vivo provides some fascinating examples of biological self-
assembly. Here, we provide a selective survey to show the diversity of functions for
which protein crystals are used, and the physical properties of the crystals that
are exploited. Where known, we emphasize how the nature of the protein-protein
interactions leads to control of the crystallization behaviour.
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1 Introduction
The crystallization of proteins in vitro is a subject of immense practical im-
portance, partly because of the vital role played by protein crystallography
in modern structural molecular biology. Thus, considerable effort has been
devoted to understanding how to crystallize proteins in the laboratory [1]. In
the last decade, colloid scientists have contributed significantly to this enter-
prise [2]. By treating globular proteins in a coarse-grained manner, it turns
out that certain regularities, such as the existence of an optimal ‘crystalliza-
tion window’, can be rationalised [3]. Initially, the simplest possible model
was used — complex protein molecules were reduced to perfect hard spheres
with isotropic, short-range inter-particle attraction. Subsequently, more realis-
tic models begin to appear. For example, the ‘stickiness’ can occur in patches
(either regular [4] or random [5]). On the other hand, the study of proteins
can give new insights into problems in colloid science, such as the existence
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of finite, equilibrium clusters in charged, attractive particle systems [6]. Thus,
the intellectual traffic between the study of protein solutions and colloidal
suspensions has proved fruitful for both sides.
Protein crystals also occur in vivo. This phenomenon is, of course, one example
of biological self-assembly. Some other examples include the formation of viral
capsids [7] and multi-protein complexes such as the ribosome [8]. Compared
to these more celebrated examples, in vivo protein crystallization has been
relatively neglected: we know of only one attempt to provide a general survey
(see the last chapter in [1]). One of the reasons for this relative neglect is
that in vivo protein crystallization is perceived to be an atypical behaviour,
and for good reason: protein aggregation and crystallization would normally
be expected to be deleterious to the cell. Indeed, the difficulty of crystallizing
proteins in vitro may reflect precisely the ‘negative selection’ that has occurred
in vivo over evolutionary time scales against easily crystallizable variants [9].
The purpose of this article is to provide a review of in vivo protein crystal-
lization from the perspective of colloid science. Unlike other articles in this
journal, many of the references will necessarily not be ‘current’ in the chrono-
logical sense — some of the first examples of in vivo protein crystals go back
nearly a century or more. However, we hope that the topic is of significant
current interest. Understanding in vivo protein crystallization, and perhaps
how cells have evolved to avoid it in the main, may be an area that is ripe
for contributions from colloid scientists. We organise the examples reviewed
according to the putative biological functions of the protein crystals in vivo.
In the concluding discussion we seek to draw together some elements of com-
monality between different kinds of in vivo protein crystals, between in vivo
and in vitro protein crystallization, as well as point to some of the interesting
differences.
2 Protein storage
Perhaps the most ‘obvious’ use for protein crystals in vivo is for storage,
either temporarily, with a view to future utilization or excretion, or as a mean
of permanent sequestration. This section gathers examples of this kind.
2.1 Seeds
It is instructive to start our review with seeds, since the occurrence of in
vivo protein crystals here is, at least at first sight, rather ‘obvious’ from a
physical sciences point of view. A major function of a seed is to act as a
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storage organ, of carbohydrates, and, in some cases, of proteins. Seed proteins
were amongst the first to be crystallized in the laboratory [1]. Given the ease
of in vitro crystallization, and the fact that many seed proteins are present
at very high concentrations, one may expect the presence of protein crystals
in vivo. This expectation is amply confirmed by reality: the packing within
membrane-bound storage organelles, ‘protein bodies’ (previously) or protein
storage vesicles (in more recent literature), often contain crystalline portions.
Indeed, protein crystals in seeds were first reported as early as 1855, and
so is one of the first known examples of in vivo crystallization. Perhaps the
most striking demonstration of crystallinity comes from diffraction from actual
seeds. In particular, dry and wet slices of seeds from rock melon and pumpkin
were found to shown powder diffraction rings consistent with a surprisingly
simple lattice (face-centred cubic) [10].
In more detail, the protein storage vesicles in most non-legume seeds consist of
three parts: an amorphous matrix, ‘crystalloids’ embedded in the matrix con-
taining proteins packed in lattice structure, and crystals of the salts of phytic
or oxalic acids (see, e.g. [11], especially the schematic drawing in Figure 1 of
this review, and Figures 10 and 11 showing lattice steps in crystalloids). The
detailed mechanism whereby such complex storage organelles are constructed
is still an active area of research [12,13]. It is clear that understanding why
some of the proteins are sequestered into crystalline compartments (e.g., is it
some form of micro-phase separation?) will be a crucial part of this enterprise.
In common with other legumes, soya beans show no evidence of crystalloids.
Nevertheless, one of the soya storage proteins provides a surprising example
of in vivo crystallinity when expressed in transgenic wheat [14]. Since the do-
mestication of Glycine max in northern China more than 3000 years ago, soya
beans have been a major source of dietary protein for a substantial fraction
of the world’s population. The two main soya storage proteins are glycinin
and β-conglycinin (often also referred to by their sedimentation coefficients as
11S and 7S) [15]. Like many other seed proteins, the wild type of both soya
proteins are easy to crystallise. Nevertheless, their atomic-resolution struc-
tures have remained illusive until recently [16,17], because crystals from the
wild-type protein do not give diffraction patterns of sufficient quality due to
‘multimer heterogeneity’. Here we concentrate on glycinin.
Glycinin is a hexamer, each monomer of which is composed of an acidic and
a basic subunit. Each pair is synthesized as a single precursor (but later
cleaved). Three of these monomers are first assembled into a trimer in the
endoplasmic reticulum. The trimer is transported to the storage vesicle, fur-
ther proteolytically modified, and then assembled into the final hexamer. The
monomer subunits are produced from multiple genes, with between 50-90%
sequence identity between them. Mixtures of these monomers assemble to give
rise to heterogeneous hexamers, which cannot give high-resolution diffraction
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patterns. One strategy to overcome this problem is to produce recombinant
glycinin in transgenic wheat containing a single type of subunit. In such trans-
genic wheat, the glycinin is observed to adopt a lattice structure when the
seed develops [14]. Thus, it appears that modifications that favour crystalline
packing (here, molecular homogeneity) but do not otherwise hinder function
do indeed lead to crystallization in vivo.
2.2 Secretory granules
Many cell types are involved in regulated secretion, in which particular pro-
teins are synthesised in significant quantities, and then stored in concentrated
form ready for release from the cell in response to some external signal. On
synthesis proteins destined for secretion enter into the rough endoplasmic retic-
ulum (RER), and then pass through the Golgi apparatus, where proteins are
sorted according to their destination. Vesicles with the relevant protein in a
condensed state form at the trans-Golgi network, and then further densify to
form the mature secretory granules [18]. The proteins in these granules are
probably more often in a dense amorphous state, but there are a significant
number of examples where they are crystalline. When secretion is triggered,
the vesicles migrate to the cell surface, and release their contents by exocytosis.
The protein granules then dissolve.
In order for this secretory pathway to be successful, the cell must exert con-
siderable control over the protein’s interactions through control of the en-
vironment experienced by the protein. Otherwise premature aggregation or
crystallization, say in the RER [19], might occur or the granule might fail to
dissolve on exocytosis. As one passes through the RER and Golgi apparatus,
the pH decreases and the concentration of divalent ions, such as Ca2+ and Zn2+
changes significantly. Indeed, aggregation has been found to occur in vitro for
a series of secretory proteins under conditions that mirror those of the trans-
Golgi cisternae [20]. Also, it is fairly common for the secretory protein to be
initially synthesised as a proprotein, which is then proteolytically processed in
the Golgi apparatus to produce the active form. This provides another avenue
to control the protein’s aggregation and crystallization properties.
It has also been suggested that the aggregation might play an important role
in the sorting of secretory proteins in the Golgi apparatus by a mechanism
called “selection by retention” [18,20]. Lysosomal proteins and those that are
part of the constitutive secretory pathway have a sorting signal in their amino
acid sequence and are actively trafficked away from the Golgi apparatus to
their correct destination. The essence of the proposed mechanism is that what
remains ends up in the regulated secretory pathway. It has been suggested
that, as well as the absence of a sorting signal, the formation of insoluble
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aggregates prevents these proteins from entering into vesicles heading to these
alternative destinations.
2.2.1 Insulin
One of the most well-known examples of regulated secretion is that of insulin,
and one for which there is a good understanding of the structural changes
associated with the secretory process [21]. Granules of insulin are secreted
from the islets of Langerhans in the pancreas into the blood in response to
elevated glucose levels in the blood. The granules are typically 200–300 nm
in size, and contain insulin in a crystal form. Insulin and proinsulin exists in
a number of oligomeric states, and this is exploited in the secretory process.
The initially synthesised proinsulin assembles into a soluble hexamer in the
presence of zinc irons. Conversion of proinsulin to insulin by cleavage of the
‘C peptide’ from the A and B chains occurs during formation of the secretory
vesicle. The insulin hexamers are insoluble in the presence of zinc ions and
crystallization occurs rapidly.
The function of the crystalline form is not clear, but it may serve to protect
the insulin from further proteolytic processing. Interestingly, in species such
as the guinea pig, where insulin is not hexameric, dense amorphous aggregates
occur instead [21]. In this context, it would be interesting to compare the rate
of proteolysis on the differently aggregated forms of insulin in vitro.
On exocytosis of the insulin granules, there is a significant increase in pH
and a decrease in concentration of Zn2+ and Ca2+. These changes lead to the
deprotonation of six glutamate residues in close proximity at the centre of the
hexamer, and the loss of the coordinating zinc ions. The resulting electrostatic
repulsion causes the crystals to dissolve rapidly to give the functionally active
monomeric form of insulin. Given this context, it is unsurprising that insulin
is one of the most rapidly crystallizing proteins in vitro.
2.2.2 White blood cells
Granulocytes are a type of white blood cell characterized by secretory granules
packed with potent chemicals that can be released to combat infection. Some
of the proteins in these granules are stored in the form of crystals. For example,
in the eosinophils depicted in Fig. 1(a), large rectangular crystals consisting of
the eosinophil major basic protein (EMBP) are apparent [22]. This protein is
synthesised as pro-EMBP, where the pro-portion of the protein is highly acidic,
presumably in order to counteract the highly basic nature of EMBP and thus
protect the cell during transport to the granule, where the pro-portion is then
removed [23].
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Eosinophils also have smaller granules containing Charcot-Leyden crystal pro-
tein [24]. Interestingly, after release of this protein by eosinophils during an in-
flammatory response, the high concentrations can lead the protein to recrystal-
lize. The resulting hexagonal bipyramidal crystals, known as Charcot-Leyden
crystals, are characteristic of eosinophil-associated allergic inflammation, such
as asthma, and were first observed in 1851 [25]. Whether this recrystallization
serves any functional purpose is not clear, but possibilities are that it provides
a way to deactivate excesses of this destructive protein, or that it provides the
first step in the removal of the protein from the tissue, e.g. the subsequent
uptake of the crystals by macrophages has been observed.
2.2.3 Protists
There are many examples of crystalline secretory granules amongst the pro-
tists [26], a diverse group of mainly single-celled eukaryotic organisms. Usually
the material extruded from the cell is for the purpose of predation of or pro-
tection against other microorganisms. Two of the most well-studied examples
are from Tetrahymena [27] and Paramecium [28], and illustrate the complexity
of crystalline secretory granules that can be formed. The secretory granule of
Paramecium, called a trichocyst, (Fig. 1(b)) involves the assembly of at least
three different families of closely related polypeptides, each localized to differ-
ent regions of the trichocyst to form a structure that is of the order of 3–4µm
in size. These polypeptides are derived by proteolytic cleavage of proproteins
during the development of the granule, and the absence of any leads to mis-
assembly of the trichocyst [29]. Furthermore, this proteolysis also serves as a
means to control the intermolecular interactions during trafficking, since the
soluble proproteins can easily pass through the endoplasmic reticulum and
the Golgi apparatus, whereas the final polypeptides are insoluble. Therefore,
proteolysis triggers aggregation, and the retention of these polypeptides in the
maturing secretory granules. Interestingly, in the absence of this proteolysis,
the proproteins end up in the constitutive secretory pathway [28].
Rapid and synchronized exocytosis in response to external stimulus is trig-
gered by the release of calcium ions leading to substantial (roughly by a factor
of 8) expansion of the crystal as it is extruded. This process is irreversible,
implying that the original assembly of the trichocyst results in a metastable
structure with energy stored in the crystal lattice. The purpose seems to be
defensive. The explosive release of the trichocysts can push Paramecium away
from a potential predator, giving it a chance to escape [30]. The physical
mechanisms causing the expansion is unknown, although it may be relevant
that the polypeptides involved are all acidic. Similar large expansions of amor-
phous polyelectrolyte gels occur in the secretory granules of mast cells, where
the negatively-charged polymer matrix exhibits a condensed state in the pres-
ence of divalent ions, but undergoes a rapid expansion in the presence of
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monovalent ions, or an electric field [31].
2.3 Bacterial parasporal crystals
On sporulation, a number of species of bacteria, the most well-studied of which
is Bacillus thuringiensis, form protein crystals containing insecticidal toxins
(Fig. 1(c)). When ingested, these crystals dissolve in the alkaline environment
of the gut of the insect larvae, releasing the protoxins which are then cleaved
to produce the active form that attacks the gut wall and facilitates entry of
germinating spores into the insect host. There is a large family of these toxins,
and the crystal structures of many of these are known [32,33]. It is common for
these proteins to be cysteine-rich and it is thought that intermolecular disul-
phide bonds contributes to their crystallization behaviour. In others, there are
strong intermolecular salt bridges. Interestingly, when expressed in a variety
of other organisms (even plants) crystal formation can still occur [34]. The
reason for packaging the toxins in a crystal is probably to provide a concen-
trated dose of toxin in a form that is insoluble at neutral pH, thus increasing
the longevity of the toxins in the environment of the soil [33].
3 Encapsulation
Some particularly interesting examples of protein crystallization occur in cer-
tain genera of insect viruses, namely cytoplasmic and nuclear polyhedrosis
viruses, granulosis viruses and entomopoxviruses [35]. All these viruses coopt
the infected cells to express large quantities of proteins (polyhedrin, granulin
and spheroidin, respectively, in the above classes) in the late stages of in-
fection. (Indeed, the baculovirus protein expression systems, one of the most
popular eukaryotic alternatives to E. coli, make use of the relevant promoter
in cut-down versions of the Autographa californica nuclear polyhedrosis virus,
where the gene for the expressed protein replaces that for polyhedrin.) These
proteins then crystallize around the the virions to provide a protective en-
vironment for the viruses after death of the insect larvae, which can remain
intact for periods of years in the soil. The viruses also induce cell lysis, aiding
release of the crystals from the dead insect larvae, and even induce larvae to
climb upwards (hence the name Wipfelkrankheit or tree-top disease) to aid
as wide dispersal as possible [36]. On ingestion of the crystals by a new in-
sect larva, the protein crystals dissolve in the alkaline environment of the gut,
releasing the virus to infect the new host.
Depending on species, the protein crystals can either encapsulate single or
multiple virus particles. The example shown in Fig. 1(d) shows a crystal en-
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capsulating a single rod-like virus particle. Particularly, interesting is the uni-
formity of the crystals — the cross-sections of the crystal are almost perfectly
circular, and the crystals are relatively monodisperse. These features raise a
host of physical questions. How does the crystal nucleate around the virus,
in this case on the surface of the membrane surrounding the virus, particu-
larly as heterogeneous nucleation usually leads to crystal growth away from
the nucleating particle [37]? What limits the growth of the crystals to a size
that is large enough to offer sufficient protection to the virus, whilst not us-
ing excessive amounts of protein? Interestingly, there is some evidence from
ultrastructural studies that for granulosis viruses, such as in Fig. 1(d), the
nucleation of the crystal usually begins at one end of the rod virus, and that
the crystal then grows around the virus [38].
The mechanical properties of the crystals are also important for their function.
Whereas most protein crystals are very fragile, in order to protect the virus,
these crystal are very tough, implying very strong interprotein interactions.
However, how then are the proteins transported to the site of crystallization
without any premature aggregation or crystallization? Indeed, if crystals of
polyhedrin produced in vivo are dissolved in alkali in vitro (having prevented
expression of a protease that co-crystallizes with polyhedrin, and whose pur-
pose is to speed up dissolution of the crystal in the alkaline environment of the
gut by cleaving polyhedrin into smaller pieces) on lowering the pH aggregation
rather than crystallization occurs [39]. Consequently, the crystal structure of
these proteins are unknown. It may be that other highly expressed proteins,
such as p10 [40], which forms filaments that are intimately associated with
the polyhedrin crystals and is involved in the formation of envelopes around
the crystals, may also play a role in the transport of polyhedrin.
4 Solid-state catalysts: Peroxisome enzymes
Peroxisomes are membrane-bound organelles found in eukaryotic cells that are
responsible for a variety of chemical processes, such as the breakdown of lipids
and alcohol, that are catalysed by enzymes, such as catalase, urate oxidase
and alcohol oxidase, that are typically assembled into regular crystals. These
reactions are usually oxidative in nature and often involve unpleasant chemical
species such as H2O2, hence the need for confinement in a specific organelle.
The crystals can be both co-crystals of a mixture of enzymes or a pure crystal
of one enzyme depending on the cell involved, and typically have an open
crystal structure with clearly observable solvent channels.
The peroxisomes in yeast cells fed on methanol provide a particularly well-
studied example [41]. In this case, the crystals are pure alcohol oxidase, and
the peroxisomes can take up a majority of the cell volume. Of course, it is im-
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portant that the enzymes do not assemble or take on their active form prior
to entry into the peroxisome. In the case of alcohol oxidase, the active form is
an octamer. After synthesis on free ribosomes in the cytosol, alcohol oxidase
binds to another protein, pyruvate carboxylase (pyc), preventing formation of
the octamer. Only after entry into the peroxisome and release from pyc, which
remains in the cytosol, does the protein form the octamer and spontaneously
assemble into a crystal. Interestingly, in mutants that lack peroxisomes, crys-
tals do not form, except at particularly high concentrations of alcohol oxidase,
when they can form in the cytoplasm [42].
Why are the enzymes organized into crystals? As the molecules that the en-
zymes act upon are trafficked to the peroxisome, there is no need for the
enzymes to diffuse through solution to find their reactants. Moreover, as the
relevant molecules are not other proteins, but are generally relatively small,
they can easily diffuse through the open crystals. The only requirement is that
the active site is not at a crystal contact. The crystals, therefore, represent
nanoporous solid-state catalysts.
5 Plugging leaks
5.1 Woronin bodies
In filamentous fungi, cellular compartments are connected by septal pores
that allow trafficking between cells. When a cell is damaged, the septal pore
is sealed by Woronin bodies, preventing cytoplasmic bleeding. Each Woronin
body is a hexagonal platelet ≈ 5µm across, and consists of a proteinaceous
core that is primarily crystalline HEX-1 surrounded by a membrane [43]. The
HEX-1 protein contains a peroxisomal targeting sequence that causes it to
be trafficked to the organelles, and thus the Woronin bodies can be classified
as peroxisomes, although, unlike most peroxisomes, they are not known to
carry out a catalytic function. HEX-1 crystallizes readily in vitro [43], and its
structure has been determined to high resolution [44].
Interestingly, a mutation exists in HEX-1 that leads to the formation of aber-
rant spherical Woronin bodies, taken by the investigators concerned as an
indication of non-crystallinity [44]. These spherical particles fail to seal septal
pores about damage to fungal hyphae. It has been suggested [44] that the
Woronin bodies require a dense core in order to withstand the intracellular
turgor pressure (which can be as high as 80 MPa [45]) and hence provide an
efficient seal. It is not clear, however, that dense amorphous packing would
achieve this any less effectively.
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5.2 Phloem sieve elements
In plants, transport in the phloem occurs along sieve tubes. The elements of
these tubes are connected by sieve plates that contain large pores. When these
cells are damaged, it is important that these pores are blocked to prevent leak-
age. This is achieved through changes to various proteinaceous bodies in the
elements [46]. One of these bodies involves P-proteins in crystalline form. In
legumes these P-protein crystalloids can undergo a reversible transformation
to a dispersed state that can plug the sieve tubes in response to the presence
of Ca2+ [47].
6 Disease induced crystallization
For most proteins, crystallization within the cellular is to be avoided, and
crystallization is a sign of dysfunction. For example, we know of two diseases
that are directly caused by protein crystallization. Firstly, hemoglobin C dis-
ease is associated with a mutant form of hemoglobin, in which a glutamate is
replaced by lysine. Crystallization of this hemoglobin C can occur in the red
blood cells of people who are homozygous for the gene encoding this mutation
(CC) or who have a combination of this and the sickle-cell gene (SC). The
former case leads to hemoglobin C disease, which is a mild form of anaemia.
The physical mechanisms of crystallization of hemoglobin C have been inten-
sively studied [48,49,50]. Secondly, mutations in the γ-crystallin proteins can
lead to cataracts. In some of these cases, the increase in lens opacity is due to
crystallization of the γ-crystallin [51].
There are then numerous examples where protein crystals have been discov-
ered to be associated with diseases in pathology samples [52], but often where
the role played by the crystals—are they the cause, a harmful side-effect or
a harmless byproduct of the disease—and even the protein that has crystal-
lized remain unclear. We have already mentioned the Charcot-Leyden crystals
associated with the action of eosinophils. Immunoglobulins, particular the κ
light chain, are another set of proteins that have a propensity to form crystals,
often in association with cancers [53].
7 Crystallization of larger proteinaceous structures
There are also many examples of larger proteinaceous bodies forming (para-)
crystalline structures in vivo. For example, in cells containing large numbers of
icosahedral viral particles, crystals are frequently seen to occur. The resulting
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iridescence due to Bragg scattering of visible light lies behind the naming of
the iridovirus family [35]. It is not clear whether this behaviour has a func-
tional purpose—perhaps the formation of a crystal maximises the room for
more viruses to be produced, or acts like a more primitive means of encap-
sulation, i.e. the viruses in the centre are protected by those on the outside,
or a means for providing a concentrated dose of the virus on transmission.
Crystal-like structures are also seen in rod-shaped viruses, such as tobacco
mosaic virus. Other examples include the formation of ribosome crystals in
hibernating animals [1], and crystalline arrays of cellulose fibres.
Two-dimensional crystals are often frequently seen. This can be of membrane
proteins, such as cytochrome oxidase [54], but also of proteins that provide
structural rigidity. For example, crystalline arrays of S-layer proteins provide
added stability to the cell envelope of many prokaryotes [55], and the CcmK
proteins form hexamers that are the building blocks for the polyhedral shell
of bacterial microcompartments, such as the carboxysome [56].
8 Conclusion
From even such a short survey — we could have provided many more exam-
ples — it is clear that protein crystallization in vivo, while not necessarily
ubiquitous, is not nearly as esoteric a phenomenon in biology as one might
have thought. In our selection, we have dwelt on those cases that are the most
well-characterized, and the function the most clear. However, in a number of
instances, particularly those associated with storage, although it is clear why
a dense state is favoured, it is less clear why that state needs to be crystalline
rather than amorphous. This is highlighted by the example of insulin granules,
which are crystalline in humans, but amorphous in guinea pigs. Any selective
advantage of the crystalline state is clearly subtle, and it might just be that
crystallization is incidental, i.e. neutral evolution has led to two equally viable
ways of storing insulin. In such cases, investigating crystallization may yield
little fruit for biology, except that the study of crystal contacts may serve to
corroborate information obtained from other means regarding the structural
consequences of mutations.
By contrast, in cases such as the Woronin bodies, the encapsulated viruses,
and the trichocysts, where the mechanical properties of these bodies is vital
to their function, understanding crystallization should also yield dividends
for understanding essential biological function. Although crystal formation
might not be necessary per se to achieve these properties, the intermolecular
interactions that induce crystallization also perform important roles in their
functions. Biophysical measurements of the mechanical properties of these
protein crystals, such as the strength of the HEX-1 and polyhedrin crystal
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or the forces generated by the expansion of the trichocysts, may also have
biological pay-offs.
Probably the biggest difference, between protein crystallization in vitro and
in vivo is that the location of the in vivo crystals is vital to their function.
In particularly, the cell needs to transport the proteins to their destination
without premature crystallization or aggregation. To achieve this, the cell
exerts an exquisite control over the interprotein interactions, that would be
the envy of any protein crystallographer. In some of the examples, we have seen
how this can be achieved through changes in the ionic environment, through
proteolysis of precursor proteins, and binding partners that “chaperone” the
proteins.
Furthermore, the architecture of the in vivo crystal, both its size and shape,
can be vital to its function. This is exemplified by the complexity of the
trichocysts. However, the mechanisms by which such control over the crystal-
lization and self-assembly is achieved are still unknown. Much can potentially
be learnt from these examples by those who would like to design and build
nanostructures. Finally, in vivo crystals are not simply passive. Rather, they
can assemble and disassemble in response to environmental signals, they can
resist mechanical stresses, and even rapidly undergo massive shape changes.
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Fig. 1. (a) Eosinophils showing granules containing dark rectangular crystals of
EMBP. (b) A trichocyst attached to the outer membrane of Paramecium. (c) A
protein toxin crystal within Bacillus thuringiensis. (d) An encapsulated virus rod
of the granulosis virus of Plodia interpunctella. Scale bars correspond to (a) 1µm
and (d) 0.1µm. Reproduced with permission from Refs. (a) [22] (b) [28], (c) [57]
and (d) [38].
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